2016 Round-upStroke research in 2016: when more medicine is better, and when it isn't
References (9)
- et al.
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
Lancet
(2016) - et al.
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
Lancet
(2016) - et al.
Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke
N Engl J Med
(2016) - et al.
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage
N Engl J Med
(2016)
Cited by (6)
Incidence and Predictors of the In-stent Restenosis after Vertebral Artery Ostium Stenting
2018, Journal of Stroke and Cerebrovascular DiseasesCitation Excerpt :In addition to intensive medical therapy, stenting in VAO was safe and effective for preventing stroke.5,6 Although the primary endpoint (any stroke during follow-up) of Vertebral artery Ischemic Stenting Trial showed no statistical deference between stenting and medical treatment arms,7 the study would lend a perspective to the benefit from extracranial vertebral artery stenting which might reduce recurrent stroke.7-9 One of the problems for stenting in VAO is in-stent restenosis (ISR), which is induced by the excessive neointimal hyperplasia in the lumen of stent and the thrombosis in the stent.
Remote limb ischemic postconditioning protects against cerebral ischemia-reperfusion injury by activating AMPK-dependent autophagy
2018, Brain Research BulletinCitation Excerpt :Stroke is one of the most common diseases with a leading cause of high morbidity and mortality worldwide (Rothwell, 2017).
Editor's Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
2018, European Journal of Vascular and Endovascular SurgeryCitation Excerpt :A systematic review, involving 672 symptomatic patients in four RCTs and six non-randomised studies between 2007 and 2015, and which compared outcomes between percutaneous transluminal angioplasty (PTA) plus BMT versus BMT alone, observed no significant benefit from PTA + BMT over BMT alone (Table 28).459 Not included in Feng's meta-analysis was the Vertebral Artery Ischaemia Stenting Trial (VIST), which presented its results at the European Stroke Organisation Conference in 2016.460,461 VIST randomised 182 patients with symptomatic intra- and extracranial VA stenoses between BMT versus angioplasty with or without stenting.
Research progress in the prevention and treatment of stroke after endovascular aortic arch repair
2023, China Journal of General SurgeryControversies in Thrombolysis
2017, Current Neurology and Neuroscience ReportsCerebral blood flow and metabolism: A quantitative approach
2017, Cerebral Blood Flow and Metabolism: A Quantitative Approach